Due to these preliminary results.

Aspirin as well as clopidogrel unlikely to prevent recurrent strokes and could increase threat of death, bleeding American Stroke Association late-breaking science – abstract LB9-4504The anti-blood clot regimen that adds the drug clopidogrel to aspirin treatment is definitely unlikely to avoid recurrent strokes and may increase the threat of bleeding and death in individuals with subcortical stroke according to late-breaking research presented at the American Stroke Association’s International Stroke Meeting 2012 http://www.avanafilincanada.com/ .


Related StoriesSeverely obese children face higher risk of developing heart disease, diabetesResearch finding offers hope for better aspirin-like drugsNew Haven Pharmaceuticals' DURLAZA medication delivers sustained antiplatelet control for full 24 hoursThe study, which Pignone may be the lead author, is released in the March 7 issue of Annals of Internal Medicine. Tools can be found that patients or doctors can use to determine an individual’s risk for coronary heart disease, including ‘Heart to Heart,’ found at the authors said. The study used released data from trials of aspirin and statin therapy to model the cost-efficiency of the therapies in middle-aged males who are at varying degrees of risk for heart disease.